nodes	percent_of_prediction	percent_of_DWPC	metapath
Octreotide—SSTR4—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.0151	0.0312	CbGpPWpGaD
Octreotide—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.0147	0.0284	CcSEcCtD
Octreotide—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0238	CcSEcCtD
Octreotide—SSTR4—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.0116	0.024	CbGpPWpGaD
Octreotide—SSTR3—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.0114	0.0237	CbGpPWpGaD
Octreotide—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0219	CcSEcCtD
Octreotide—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.0213	CcSEcCtD
Octreotide—SSTR1—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.011	0.0227	CbGpPWpGaD
Octreotide—SSTR5—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.00972	0.0201	CbGpPWpGaD
Octreotide—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00971	0.0188	CcSEcCtD
Octreotide—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.00901	0.0174	CcSEcCtD
Octreotide—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.00901	0.0174	CcSEcCtD
Octreotide—SSTR2—Peptide GPCRs—AGTR2—focal segmental glomerulosclerosis	0.00897	0.0186	CbGpPWpGaD
Octreotide—Gastrointestinal symptom NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00891	0.0172	CcSEcCtD
Octreotide—SSTR3—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.00879	0.0182	CbGpPWpGaD
Octreotide—SSTR1—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.00843	0.0175	CbGpPWpGaD
Octreotide—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00808	0.0156	CcSEcCtD
Octreotide—Peptic ulcer—Cyclosporine—focal segmental glomerulosclerosis	0.00784	0.0152	CcSEcCtD
Octreotide—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00769	0.0149	CcSEcCtD
Octreotide—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00754	0.0146	CcSEcCtD
Octreotide—SSTR5—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.00748	0.0155	CbGpPWpGaD
Octreotide—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00733	0.0142	CcSEcCtD
Octreotide—SSTR4—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.0071	0.0147	CbGpPWpGaD
Octreotide—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.00696	0.0135	CcSEcCtD
Octreotide—SSTR2—Peptide GPCRs—AGTR1—focal segmental glomerulosclerosis	0.0069	0.0143	CbGpPWpGaD
Octreotide—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.0069	0.0133	CcSEcCtD
Octreotide—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00673	0.013	CcSEcCtD
Octreotide—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.0126	CcSEcCtD
Octreotide—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.00647	0.0125	CcSEcCtD
Octreotide—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00623	0.012	CcSEcCtD
Octreotide—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00613	0.0119	CcSEcCtD
Octreotide—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.006	0.0116	CcSEcCtD
Octreotide—SSTR4—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00599	0.0124	CbGpPWpGaD
Octreotide—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00596	0.0115	CcSEcCtD
Octreotide—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.0112	CcSEcCtD
Octreotide—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0058	0.0112	CcSEcCtD
Octreotide—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00576	0.0111	CcSEcCtD
Octreotide—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00576	0.0111	CcSEcCtD
Octreotide—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00576	0.0111	CcSEcCtD
Octreotide—Herpes simplex—Cyclosporine—focal segmental glomerulosclerosis	0.00568	0.011	CcSEcCtD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00555	0.0115	CbGpPWpGaD
Octreotide—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.0106	CcSEcCtD
Octreotide—SSTR4—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.00546	0.0113	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00538	0.0111	CbGpPWpGaD
Octreotide—MPO—IL23-mediated signaling events—NOS2—focal segmental glomerulosclerosis	0.00517	0.0107	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00516	0.0107	CbGpPWpGaD
Octreotide—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00995	CcSEcCtD
Octreotide—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00995	CcSEcCtD
Octreotide—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00509	0.00984	CcSEcCtD
Octreotide—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.005	0.00967	CcSEcCtD
Octreotide—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00951	CcSEcCtD
Octreotide—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00481	0.00931	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00476	0.00985	CbGpPWpGaD
Octreotide—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00474	0.00916	CcSEcCtD
Octreotide—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00469	0.00907	CcSEcCtD
Octreotide—SSTR4—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.00463	0.00958	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00457	0.00947	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00454	0.00939	CbGpPWpGaD
Octreotide—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00846	CcSEcCtD
Octreotide—SSTR1—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00435	0.009	CbGpPWpGaD
Octreotide—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00433	0.00838	CcSEcCtD
Octreotide—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.0083	CcSEcCtD
Octreotide—SSTR4—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00427	0.00884	CbGpPWpGaD
Octreotide—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00425	0.00822	CcSEcCtD
Octreotide—SSTR2—Peptide ligand-binding receptors—AGTR2—focal segmental glomerulosclerosis	0.00422	0.00874	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00421	0.00872	CbGpPWpGaD
Octreotide—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.008	CcSEcCtD
Octreotide—SSTR3—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.00413	0.00856	CbGpPWpGaD
Octreotide—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.00786	CcSEcCtD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00404	0.00836	CbGpPWpGaD
Octreotide—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00403	0.00779	CcSEcCtD
Octreotide—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00401	0.00776	CcSEcCtD
Octreotide—SSTR1—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.00396	0.00821	CbGpPWpGaD
Octreotide—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00393	0.0076	CcSEcCtD
Octreotide—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00391	0.00757	CcSEcCtD
Octreotide—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0039	0.00754	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00386	0.00799	CbGpPWpGaD
Octreotide—SSTR4—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.00384	0.00795	CbGpPWpGaD
Octreotide—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0038	0.00735	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00366	0.00758	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00362	0.0075	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00361	0.00747	CbGpPWpGaD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.00358	0.00741	CbGpPWpGaD
Octreotide—SSTR2—G alpha (i) signalling events—AGTR2—focal segmental glomerulosclerosis	0.00356	0.00737	CbGpPWpGaD
Octreotide—SSTR5—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.00352	0.00728	CbGpPWpGaD
Octreotide—SSTR3—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.00351	0.00726	CbGpPWpGaD
Octreotide—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.00349	0.00674	CcSEcCtD
Octreotide—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00672	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00346	0.00716	CbGpPWpGaD
Octreotide—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.00662	CcSEcCtD
Octreotide—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.00651	CcSEcCtD
Octreotide—MPO—Vitamin B12 Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.00337	0.00697	CbGpPWpGaD
Octreotide—SSTR1—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.00336	0.00696	CbGpPWpGaD
Octreotide—MPO—Vitamin B12 Metabolism—ALB—focal segmental glomerulosclerosis	0.00336	0.00695	CbGpPWpGaD
Octreotide—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00335	0.00649	CcSEcCtD
Octreotide—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00331	0.0064	CcSEcCtD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0033	0.00684	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—AGTR1—focal segmental glomerulosclerosis	0.00324	0.00672	CbGpPWpGaD
Octreotide—SSTR4—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00324	0.00671	CbGpPWpGaD
Octreotide—SSTR3—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00324	0.0067	CbGpPWpGaD
Octreotide—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00625	CcSEcCtD
Octreotide—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.00623	CcSEcCtD
Octreotide—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00619	CcSEcCtD
Octreotide—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00316	0.00611	CcSEcCtD
Octreotide—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00315	0.00609	CcSEcCtD
Octreotide—SSTR1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.0031	0.00643	CbGpPWpGaD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.0031	0.00642	CbGpPWpGaD
Octreotide—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.00594	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00307	0.00635	CbGpPWpGaD
Octreotide—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00305	0.00591	CcSEcCtD
Octreotide—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00587	CcSEcCtD
Octreotide—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00579	CcSEcCtD
Octreotide—SSTR5—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.00298	0.00617	CbGpPWpGaD
Octreotide—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.00575	CcSEcCtD
Octreotide—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00296	0.00573	CcSEcCtD
Octreotide—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00295	0.0057	CcSEcCtD
Octreotide—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00292	0.00565	CcSEcCtD
Octreotide—SSTR3—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.00291	0.00602	CbGpPWpGaD
Octreotide—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00556	CcSEcCtD
Octreotide—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.00552	CcSEcCtD
Octreotide—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00551	CcSEcCtD
Octreotide—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00551	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00283	0.00586	CbGpPWpGaD
Octreotide—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00279	0.0054	CcSEcCtD
Octreotide—SSTR1—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.00279	0.00578	CbGpPWpGaD
Octreotide—SSTR4—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00279	0.00577	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00277	0.00574	CbGpPWpGaD
Octreotide—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.00277	0.00536	CcSEcCtD
Octreotide—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00535	CcSEcCtD
Octreotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00275	0.0057	CbGpPWpGaD
Octreotide—SSTR2—Peptide ligand-binding receptors—EDN1—focal segmental glomerulosclerosis	0.00275	0.0057	CbGpPWpGaD
Octreotide—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00275	0.00532	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00275	0.00569	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—SERPINE1—focal segmental glomerulosclerosis	0.00274	0.00567	CbGpPWpGaD
Octreotide—MPO—Folate Metabolism—ALB—focal segmental glomerulosclerosis	0.00273	0.00566	CbGpPWpGaD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00266	0.00551	CbGpPWpGaD
Octreotide—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00264	0.0051	CcSEcCtD
Octreotide—SSTR1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00263	0.00545	CbGpPWpGaD
Octreotide—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00263	0.00509	CcSEcCtD
Octreotide—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.00506	CcSEcCtD
Octreotide—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00261	0.00505	CcSEcCtD
Octreotide—SSTR4—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00258	0.00533	CbGpPWpGaD
Octreotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00254	0.00526	CbGpPWpGaD
Octreotide—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00254	0.0049	CcSEcCtD
Octreotide—SSTR5—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.00247	0.00512	CbGpPWpGaD
Octreotide—SSTR3—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00245	0.00508	CbGpPWpGaD
Octreotide—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.00474	CcSEcCtD
Octreotide—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00472	CcSEcCtD
Octreotide—SSTR4—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00236	0.00489	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00236	0.00488	CbGpPWpGaD
Octreotide—SSTR1—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00235	0.00487	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00235	0.00487	CbGpPWpGaD
Octreotide—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.00455	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00234	0.00484	CbGpPWpGaD
Octreotide—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00232	0.0045	CcSEcCtD
Octreotide—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00446	CcSEcCtD
Octreotide—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00443	CcSEcCtD
Octreotide—SSTR2—Peptide ligand-binding receptors—AGT—focal segmental glomerulosclerosis	0.00228	0.00473	CbGpPWpGaD
Octreotide—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00226	0.00436	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00225	0.00467	CbGpPWpGaD
Octreotide—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00435	CcSEcCtD
Octreotide—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00222	0.0043	CcSEcCtD
Octreotide—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0022	0.00426	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00218	0.00451	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—SERPINE1—focal segmental glomerulosclerosis	0.00218	0.0045	CbGpPWpGaD
Octreotide—MPO—Selenium Micronutrient Network—ALB—focal segmental glomerulosclerosis	0.00217	0.0045	CbGpPWpGaD
Octreotide—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.00417	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00216	0.00446	CbGpPWpGaD
Octreotide—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00415	CcSEcCtD
Octreotide—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00411	CcSEcCtD
Octreotide—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00409	CcSEcCtD
Octreotide—SSTR3—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00211	0.00437	CbGpPWpGaD
Octreotide—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00407	CcSEcCtD
Octreotide—SSTR5—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00209	0.00432	CbGpPWpGaD
Octreotide—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00399	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00206	0.00426	CbGpPWpGaD
Octreotide—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00206	0.00398	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00205	0.00424	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00202	0.00419	CbGpPWpGaD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.002	0.00414	CbGpPWpGaD
Octreotide—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00387	CcSEcCtD
Octreotide—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00384	CcSEcCtD
Octreotide—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00382	CcSEcCtD
Octreotide—SSTR4—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00196	0.00406	CbGpPWpGaD
Octreotide—SSTR3—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00195	0.00404	CbGpPWpGaD
Octreotide—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00377	CcSEcCtD
Octreotide—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00377	CcSEcCtD
Octreotide—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00195	0.00377	CcSEcCtD
Octreotide—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00376	CcSEcCtD
Octreotide—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00374	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00194	0.00401	CbGpPWpGaD
Octreotide—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00373	CcSEcCtD
Octreotide—SSTR2—G alpha (i) signalling events—AGT—focal segmental glomerulosclerosis	0.00193	0.00399	CbGpPWpGaD
Octreotide—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00191	0.00369	CcSEcCtD
Octreotide—SSTR1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00187	0.00387	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00187	0.00387	CbGpPWpGaD
Octreotide—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00361	CcSEcCtD
Octreotide—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00187	0.00361	CcSEcCtD
Octreotide—SSTR4—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00186	0.00385	CbGpPWpGaD
Octreotide—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00186	0.00359	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00185	0.00382	CbGpPWpGaD
Octreotide—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00355	CcSEcCtD
Octreotide—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00354	CcSEcCtD
Octreotide—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00182	0.00351	CcSEcCtD
Octreotide—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00349	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.0018	0.00372	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00179	0.00371	CbGpPWpGaD
Octreotide—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00178	0.00345	CcSEcCtD
Octreotide—SSTR4—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00178	0.00368	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00172	0.00357	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00172	0.00355	CbGpPWpGaD
Octreotide—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00329	CcSEcCtD
Octreotide—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00327	CcSEcCtD
Octreotide—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00325	CcSEcCtD
Octreotide—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00167	0.00322	CcSEcCtD
Octreotide—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00321	CcSEcCtD
Octreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00166	0.00344	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00166	0.00343	CbGpPWpGaD
Octreotide—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00318	CcSEcCtD
Octreotide—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00314	CcSEcCtD
Octreotide—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00312	CcSEcCtD
Octreotide—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00312	CcSEcCtD
Octreotide—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00309	CcSEcCtD
Octreotide—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00309	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00157	0.00326	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00156	0.00324	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00156	0.00323	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00155	0.00321	CbGpPWpGaD
Octreotide—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00298	CcSEcCtD
Octreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00153	0.00317	CbGpPWpGaD
Octreotide—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.00296	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00152	0.00315	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.0015	0.00311	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0015	0.0031	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00149	0.00308	CbGpPWpGaD
Octreotide—SSTR3—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00149	0.00308	CbGpPWpGaD
Octreotide—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00287	CcSEcCtD
Octreotide—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00286	CcSEcCtD
Octreotide—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00286	CcSEcCtD
Octreotide—SSTR3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00147	0.00304	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00143	0.00296	CbGpPWpGaD
Octreotide—SSTR1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00142	0.00295	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00142	0.00294	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00141	0.00292	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00141	0.00291	CbGpPWpGaD
Octreotide—SSTR2—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.0014	0.00291	CbGpPWpGaD
Octreotide—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00266	CcSEcCtD
Octreotide—SSTR1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00136	0.00281	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00135	0.0028	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00135	0.00279	CbGpPWpGaD
Octreotide—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00259	CcSEcCtD
Octreotide—SSTR4—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00134	0.00276	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00133	0.00275	CbGpPWpGaD
Octreotide—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00132	0.00256	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00132	0.00273	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0013	0.0027	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00129	0.00268	CbGpPWpGaD
Octreotide—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00247	CcSEcCtD
Octreotide—SSTR5—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00126	0.00262	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00125	0.00259	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00125	0.00258	CbGpPWpGaD
Octreotide—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00239	CcSEcCtD
Octreotide—SSTR2—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00122	0.00254	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00122	0.00252	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00121	0.00251	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00121	0.0025	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.0012	0.00248	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00119	0.00247	CbGpPWpGaD
Octreotide—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0023	CcSEcCtD
Octreotide—SSTR3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00119	0.00245	CbGpPWpGaD
Octreotide—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00228	CcSEcCtD
Octreotide—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00228	CcSEcCtD
Octreotide—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00117	0.00226	CcSEcCtD
Octreotide—SSTR2—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00117	0.00241	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00115	0.00238	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00115	0.00237	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00114	0.00237	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00114	0.00236	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00114	0.00235	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00111	0.0023	CbGpPWpGaD
Octreotide—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00215	CcSEcCtD
Octreotide—SSTR5—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00111	0.0023	CbGpPWpGaD
Octreotide—SSTR4—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00111	0.00229	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00111	0.00229	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.0011	0.00229	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.0011	0.00227	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00109	0.00226	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00108	0.00224	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00106	0.00219	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00104	0.00215	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00102	0.00212	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00101	0.0021	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00101	0.0021	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00101	0.00209	CbGpPWpGaD
Octreotide—SSTR4—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00101	0.00208	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00097	0.00201	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000968	0.002	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.000937	0.00194	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00093	0.00193	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000924	0.00191	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.000922	0.00191	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000919	0.0019	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.000894	0.00185	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000881	0.00182	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00086	0.00178	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00085	0.00176	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000845	0.00175	CbGpPWpGaD
Octreotide—SSTR3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00084	0.00174	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000837	0.00173	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000833	0.00172	CbGpPWpGaD
Octreotide—SSTR1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000805	0.00167	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000803	0.00166	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000798	0.00165	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000794	0.00164	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000781	0.00162	CbGpPWpGaD
Octreotide—SSTR3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000763	0.00158	CbGpPWpGaD
Octreotide—SSTR1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000731	0.00151	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000721	0.00149	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000716	0.00148	CbGpPWpGaD
Octreotide—SSTR5—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000714	0.00148	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000712	0.00147	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000708	0.00147	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.0007	0.00145	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000695	0.00144	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000671	0.00139	CbGpPWpGaD
Octreotide—SSTR2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000659	0.00136	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000658	0.00136	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000657	0.00136	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000653	0.00135	CbGpPWpGaD
Octreotide—SSTR5—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000648	0.00134	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00064	0.00133	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000614	0.00127	CbGpPWpGaD
Octreotide—SSTR2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000598	0.00124	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000595	0.00123	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000594	0.00123	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000549	0.00114	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000549	0.00114	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000544	0.00113	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000543	0.00112	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000527	0.00109	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00052	0.00108	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000505	0.00105	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000502	0.00104	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000499	0.00103	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000478	0.00099	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000462	0.000956	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000457	0.000946	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000451	0.000933	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000448	0.000927	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000432	0.000894	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000426	0.000882	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000424	0.000878	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000416	0.000862	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000413	0.000856	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000399	0.000826	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000391	0.00081	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000383	0.000793	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000354	0.000733	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000354	0.000732	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00035	0.000725	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000346	0.000717	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000332	0.000688	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000327	0.000676	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000295	0.00061	CbGpPWpGaD
Octreotide—SSTR4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000289	0.000597	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000272	0.000563	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000265	0.000549	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000254	0.000527	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000226	0.000467	CbGpPWpGaD
Octreotide—SSTR3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000219	0.000453	CbGpPWpGaD
Octreotide—SSTR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00021	0.000434	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000208	0.000431	CbGpPWpGaD
Octreotide—SSTR5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000186	0.000385	CbGpPWpGaD
Octreotide—SSTR2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000172	0.000355	CbGpPWpGaD
